News

Syneos Health has tapped Costa Panagos to take the reins from former CEO Colin Shannon, who will transition to the role of executive chair. Panagos recently served as president of R&D solutions at ...
Over the summer, Syneos Health U.S. PR also appointed Matthew Snodgrass as its artificial intelligence innovation lead. According to the MM+M Agency 100 revenue chart, Syneos Health’s revenue jumped 4 ...
Syneos Health has terminated an incentives agreement with the state months after being taken private in a multibillion-dollar deal. People to Watch in 2024: Syneos Health CEO Colin Shannon Days ...
Syneos Health SYNH recently entered into a definitive agreement to be acquired by a private investment consortium in an all-cash transaction of approximately $7.1 billion. The consortium of private ...
Shareholders to Receive $43.00 Per Share in Cash Represents 24% Premium to Unaffected Stock Price MORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos ...
Syneos Health SYNH recently signed a strategic multi-year agreement with Microsoft to increase AI usage across its clinical and commercial activities for biopharma customers. Under the deal, the ...
Syneos Health (SYNH) may be worth toward the midpoint of a range of $40-$53 a share, according to a Barclays analyst.The analysis comes after after a Monday report that the ...
Within the last quarter, Syneos Health (NASDAQ:SYNH) has observed the following analyst ratings: These 7 analysts have an average price target of $35.71 versus the current price of Syneos Health ...
Syneos Health Inc is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a 52% plunge in its shares over the past year ...